Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.22), versus ($1.07) reported last year.
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.22), versus ($1.07) reported last year.
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.